Zobrazeno 1 - 10
of 57
pro vyhledávání: '"M H, Dykes"'
Autor:
Ruben J. Colman, Dana M. H. Dykes, Ana Catalina Arce-Clachar, Shehzad A. Saeed, Phillip Minar
Publikováno v:
Pediatric Inflammatory Bowel Disease ISBN: 9783031147432
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81e287697b722c9812d01812eafe54bc
https://doi.org/10.1007/978-3-031-14744-9_31
https://doi.org/10.1007/978-3-031-14744-9_31
Autor:
Lee A. Denson, Laura E Bauman, Deepika L. Chona, John L. Lyles, Lin Fei, Weizhe Su, Jennifer Hellmann, Puneet Sharma, Renee K Etter, Michael J. Rosen, Phillip Minar, Dana M. H. Dykes, Aditi Mulgund
Publikováno v:
Inflamm Bowel Dis
Background Reports on the feasibility and effectiveness of translating proactive, antitumor necrosis factor (TNF) therapeutic drug monitoring (TDM) for inflammatory bowel disease into practice-wide quality improvement (QI) are lacking. We aimed to de
Autor:
Jennifer Hellmann, Michael J. Rosen, Phillip Minar, Denise Hill, Dana M. H. Dykes, Renee K Etter, Lee A. Denson
Publikováno v:
Pediatric Quality & Safety
Supplemental Digital Content is available in the text.
Introduction: Achieving and maintaining target serum trough infliximab levels improves outcomes in children and young adults with inflammatory bowel disease. Our goal was to improve adherenc
Introduction: Achieving and maintaining target serum trough infliximab levels improves outcomes in children and young adults with inflammatory bowel disease. Our goal was to improve adherenc
Autor:
Dana M. H. Dykes, Sean R. Moore, D. Brent Polk, Michael J. Rosen, Marcia L. Wills, Brian Morris, Jeanine S. Maclin, Janaina Nogueira, Avi Katz, Tracey E. Hunley, Judith Pugh, Shehzad Saeed
Publikováno v:
Case Reports in Pediatrics, Vol 2012 (2012)
Mycophenolate mofetil (MMF) is an immunosuppressive medication utilized in the management of both autoimmune and solid organ transplant patients. Diarrhea is a common gastrointestinal side effect of MMF, but more severe forms of GI symptoms are descr
Externí odkaz:
https://doaj.org/article/b0b0e9376994423887b49d1b269fad24
Autor:
Edward J. Hoffenberg, Dana M. H. Dykes, Leah Siebold, Joseph A. Picoraro, Sandra C. Kim, Jonathan Moses, Elaine Barfield, K.T. Park, Ghassan Wahbeh, Andrew B. Grossman, Robbyn Sockolow, Shehzad Ahmed Saeed
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 66:680-686
The primary aim of this Clinical Report by the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition is to provide formal guidance to pediatric gastroenterologists and clinicians, health systems, and insurance payers regardi
Autor:
Dana M. H. Dykes, Wendy N. Gray, Shehzad Ahmed Saeed, Lee A. Denson, Pamela Morgan, Erin Holbrook
Publikováno v:
Journal of pediatric gastroenterology and nutrition. 69(2)
Deficits in the preparation of patients with inflammatory bowel disease (IBD) who are transitioning to adult care are known yet studies presenting outcome data of transition interventions in IBD are lacking. We present data evaluating the impact of a
Autor:
Gary L. McPhail, Shehzad Ahmed Saeed, Ian Eslick, Dana M. H. Dykes, Sunny Thakkar, Peter A. Margolis, Lisa Burns, Barbara A. Chini, Heather C. Kaplan, Lisa Opipari-Arrigan
Publikováno v:
JMIR mHealth and uHealth
JMIR mHealth and uHealth, Vol 8, Iss 11, p e11968 (2020)
JMIR mHealth and uHealth, Vol 8, Iss 11, p e11968 (2020)
Background Mobile health (mHealth) technology has the potential to support the Chronic Care Model’s vision of closed feedback loops and patient-clinician partnerships. Objective This study aims to evaluate the feasibility, acceptability, and short-
Autor:
Lisa Opipari-Arrigan, Dana M H Dykes, Shehzad A Saeed, Sunny Thakkar, Lisa Burns, Barbara A Chini, Gary L McPhail, Ian Eslick, Peter A Margolis, Heather C Kaplan
BACKGROUND Mobile health (mHealth) technology has the potential to support the Chronic Care Model’s vision of closed feedback loops and patient-clinician partnerships. OBJECTIVE This study aims to evaluate the feasibility, acceptability, and short-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30ec0d2ca1b9a2b1b7031efb6c76958b
https://doi.org/10.2196/preprints.11968
https://doi.org/10.2196/preprints.11968
Autor:
Abdul Elkadri, Dana M. H. Dykes, Laura Bauman, Alisa J. Muñiz Crim, Sabina Ali, Marisa R. Izaguirre, Matthew W Carroll, Andrew B. Grossman, Wael El-Matary, Jennifer deBruyn, Charles M. Samson
BACKGROUND: Infliximab (IFX) infusion may lead to development of anti-IFX antibodies, and subsequent infusion reactions (IRs). The safety of rapid IFX infusion administered over 60 minutes has been under-investigated in children with inflammatory bow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c90967c1aa3a2a8337280c48a09b87e
https://europepmc.org/articles/PMC6551232/
https://europepmc.org/articles/PMC6551232/
Publikováno v:
Pediatric Inflammatory Bowel Disease ISBN: 9783319492131
The inflammatory bowel diseases (IBDs), including Crohn disease and ulcerative colitis, are chronic inflammatory disorders of the gastrointestinal tract most often diagnosed in adolescence and young adulthood, with a rising incidence in pediatric pop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51dfacf4df41241a71d59d2a81abc682
https://doi.org/10.1007/978-3-319-49215-5_32
https://doi.org/10.1007/978-3-319-49215-5_32